Frontiers in Cardiovascular Medicine
Scope & Guideline
Championing Breakthroughs in Heart Health Science.
Introduction
Aims and Scopes
- Cardiovascular Disease Mechanisms:
Focuses on understanding the underlying biological and physiological mechanisms that contribute to various cardiovascular diseases, including ischemic heart disease, heart failure, and arrhythmias. - Innovative Therapeutics and Interventions:
Explores novel therapeutic strategies, including pharmacological treatments, device-based interventions, and surgical techniques aimed at improving outcomes for patients with cardiovascular conditions. - Diagnostic and Imaging Technologies:
Covers advancements in diagnostic methodologies and imaging technologies, such as echocardiography, magnetic resonance imaging, and computed tomography, to enhance the assessment of cardiovascular health. - Epidemiology and Public Health:
Investigates the epidemiological aspects of cardiovascular diseases, focusing on risk factors, preventive strategies, and the impact of lifestyle and socioeconomic factors on cardiovascular health. - Translational Research:
Emphasizes the translation of basic science discoveries into clinical applications to improve patient outcomes in cardiovascular care. - Patient-Centered Approaches:
Promotes research that evaluates patient perspectives, quality of life, and outcomes in cardiovascular care, ensuring that patient needs and experiences are central to cardiovascular research.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a growing trend in the application of artificial intelligence and machine learning techniques for predicting outcomes, diagnosing diseases, and personalizing treatment in cardiovascular medicine. - Cardio-Oncology:
Research focusing on the intersection of cardiovascular health and cancer treatment is gaining traction, addressing the cardiotoxic effects of cancer therapies and the management of cardiovascular disease in cancer patients. - Integrated Multidisciplinary Approaches:
A shift towards integrated care models that encompass cardiology, endocrinology, nephrology, and other specialties to address the multifactorial nature of cardiovascular diseases is becoming increasingly prevalent. - Personalized and Precision Medicine:
Emerging interest in tailoring cardiovascular treatment strategies based on genetic, phenotypic, and lifestyle factors, promoting individualized patient care in cardiovascular medicine. - Regenerative Medicine and Stem Cell Therapy:
Research into the use of stem cells and regenerative therapies to repair and regenerate cardiac tissue is on the rise, reflecting a shift towards innovative treatment modalities. - Telemedicine and Remote Monitoring:
An increase in studies focusing on telemedicine and remote patient monitoring technologies, particularly in the context of managing chronic cardiovascular diseases and during the COVID-19 pandemic.
Declining or Waning
- Traditional Pharmacological Approaches:
There is a noticeable decline in research focused solely on traditional pharmacological treatments for cardiovascular diseases, as newer therapies and combination approaches gain prominence. - Basic Science Studies Without Clinical Relevance:
Research primarily focused on basic science without clear translational implications appears to be decreasing, as the journal emphasizes studies that bridge the gap between laboratory findings and clinical applications. - Isolated Risk Factor Studies:
Studies that examine single risk factors in isolation, such as hypertension or hyperlipidemia, are becoming less frequent, with a shift towards more integrative approaches that consider multiple interacting factors. - Surgical Interventions Without Technological Integration:
Research on traditional surgical methods without the incorporation of new technologies or techniques has seen a decline, as the field moves toward more innovative, technology-driven approaches.
Similar Journals
Journal of Cardiology
Innovating solutions for a world of cardiovascular challenges.Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.
Minerva Cardiology and Angiology
Advancing cardiovascular knowledge for a healthier tomorrow.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
ACTA CARDIOLOGICA
Transforming challenges into solutions in cardiology.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Journal of Cardiovascular Development and Disease
Advancing cardiovascular knowledge for a healthier tomorrow.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
CANADIAN JOURNAL OF CARDIOLOGY
Elevating Standards in Cardiovascular ResearchCanadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.
Korean Circulation Journal
Connecting Researchers and Practitioners for Heart Health Advancements.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.
Cardiology Journal
Elevating standards in heart health scholarship.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
Journal of the Saudi Heart Association
Championing Open Access to Cardiovascular ResearchThe Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.
Nepalese Heart Journal
Connecting Researchers and Clinicians for a Healthier FutureNepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.
Journal of Cardiovascular Medicine
Exploring New Horizons in Cardiovascular MedicineWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.